These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10355218)

  • 1. Clinical experience with oral ketamine.
    Enarson MC; Hays H; Woodroffe MA
    J Pain Symptom Manage; 1999 May; 17(5):384-6. PubMed ID: 10355218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain.
    Haines DR; Gaines SP
    Pain; 1999 Nov; 83(2):283-7. PubMed ID: 10534600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.
    Rabben T; Øye I
    Eur J Pain; 2001; 5(3):233-40. PubMed ID: 11558979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine in pain management.
    Cohen SP; Liao W; Gupta A; Plunkett A
    Adv Psychosom Med; 2011; 30():139-161. PubMed ID: 21508630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.
    Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):750-8. PubMed ID: 9698948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ketamine in pain management.
    Visser E; Schug SA
    Biomed Pharmacother; 2006 Aug; 60(7):341-8. PubMed ID: 16854557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit.
    Fitzgibbon EJ; Viola R
    J Palliat Med; 2005 Feb; 8(1):49-57. PubMed ID: 15662173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the use of ketamine in pain management.
    Tawfic QA
    J Opioid Manag; 2013; 9(5):379-88. PubMed ID: 24353050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial.
    Noppers I; Niesters M; Swartjes M; Bauer M; Aarts L; Geleijnse N; Mooren R; Dahan A; Sarton E
    Eur J Pain; 2011 Oct; 15(9):942-9. PubMed ID: 21482474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects of ketamine in the long-term treatment of neuropathic pain.
    Cvrcek P
    Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of oral ketamine in chronic pain management: a review.
    Blonk MI; Koder BG; van den Bemt PM; Huygen FJ
    Eur J Pain; 2010 May; 14(5):466-72. PubMed ID: 19879174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine for chronic pain: risks and benefits.
    Niesters M; Martini C; Dahan A
    Br J Clin Pharmacol; 2014 Feb; 77(2):357-67. PubMed ID: 23432384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effects of topical ketamine.
    Kopsky DJ; Keppel Hesselink JM; Bhaskar A; Hariton G; Romanenko V; Casale R
    Minerva Anestesiol; 2015 Apr; 81(4):440-9. PubMed ID: 24847738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of ketamine as adjuvant therapy to control severe pain.
    Campbell-Fleming JM; Williams A
    Clin J Oncol Nurs; 2008 Feb; 12(1):102-7. PubMed ID: 18258579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ketamine in uncontrolled acute and procedural pain.
    Chumbley G
    Nurs Stand; 2010 Dec 15-2011 Jan 4; 25(15-17):35-7. PubMed ID: 21309429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine.
    Fitzgibbon EJ; Hall P; Schroder C; Seely J; Viola R
    J Pain Symptom Manage; 2002 Feb; 23(2):165-70. PubMed ID: 11844639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.